Ac-DOTA-TATE in SSTR2-positive tumor models
Prachi Bharat Desai, Dennis Mewis, Marion Huber, Manuel Sturzbecher‐Hoehne, Manfred Ruediger, Germo Gericke, Anika Jaekel
This study compares the therapeutic efficacy of SSO110 radiolabeled with different radionuclides in SSTR2-positive tumor models, finding that [225Ac]Ac-SSO110 shows the highest anti-tumor activity.
bioRxiv · Mar 14, 2026 · PreprintCancer Biology